Y. Dagan et al., EVALUATING THE ROLE OF MELATONIN IN THE LONG-TERM TREATMENT OF DELAYED SLEEP PHASE SYNDROME (DSPS), Chronobiology international, 15(2), 1998, pp. 181-190
Delayed sleep phase syndrome (DSPS) involves a mismatch between the us
ual daily schedule required by the individual's environment and his or
her circadian sleep-wake pattern. Patients suffering from DSPS are tr
eated with chronotherapy, light therapy, or melatonin administration.
While chronotherapy and light therapy are demanding and difficult trea
tments that usually lead to compliance problems, melatonin administrat
ion is a relatively simple and easy treatment option. Previous studies
carried out on relatively small samples of DSPS patients have shown t
hat melatonin has a sleep-promoting and entraining action when taken i
n the evening. The present study, which accompanied routine treatment
in our sleep clinic, examined the efficiency of melatonin treatment in
a relatively large population of DSPS subjects by means of subjective
reports. The 61 subjects, 37 males and 24 females, were diagnosed wit
h DSPS by means of clinical assessment and actigraphy at our sleep cli
nic. Their mean pretreatment falling asleep and waking times were 03:0
9 (SD = 86.22 minutes) and 11:31 (SD = 98.58 minutes), respectively. T
hey were treated with a 6-week course of 5 mg of oral melatonin taken
daily at 22:00. A survey questionnaire was sent to the home of each su
bject 12-18 months after the end of the treatment; the survey investig
ated the efficiency of the melatonin treatment and its possible side e
ffects. Of the patients, 96.7% reported that the melatonin treatment w
as helpful, with almost no side effects. Of these, 91.5% reported a re
lapse to their pre-treatment sleeping patterns within 1 year of the en
d of treatment. Only 28.8% reported that the relapse occurred within 1
week. The pretreatment falling asleep and waking times of patients in
whom the changes were retained for a relatively long period of time w
ere significantly earlier than those of patients whose relapse was imm
ediate (t = 2.18, p<.05; t = 2.39, p<.05, respectively), with no diffe
rence in sleep duration. The implications of these findings, as well a
s further research possibilities, are discussed.